The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects
- 27 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 124 (2), 475-479
- https://doi.org/10.1007/s10549-010-0858-3
Abstract
Published data on the association between p21 Ser31Arg polymorphism and breast cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Crude ORs with 95% CIs were used to assess the strength of association between the p21 Ser31Arg polymorphism and breast cancer risk. The pooled ORs were performed for co-dominant model (Ser/Arg vs. Ser/Ser, Arg/Arg vs. Ser/Ser), dominant model (Arg/Arg + Ser/Arg vs. Ser/Ser), and recessive model (Arg/Arg vs. Ser/Arg + Ser/Ser). A total of 21 studies including 22,109 cases and 29,127 controls were involved in this meta-analysis. Overall, no significant associations were found between p21 Ser31Arg polymorphism and breast cancer risk when all studies pooled into the meta-analysis. In the subgroup analysis by ethnicity, significantly increased risk was found for Caucasians (Arg/Arg vs. Ser/Ser: OR 1.496, 95% CI 1.164-1.924; and recessive model: OR 1.492, 95% CI 1.161-1.919). When stratified by study design, statistically significantly elevated risk was found for population-based studies (Ser/Arg vs. Ser/Ser: OR 1.085, 95% CI 1.019-1.156). In conclusion, this meta-analysis suggests that the p21 Ser31Arg polymorphism may be associated with breast cancer development in Caucasian. However, large sample and representative population-based studies with homogeneous breast cancer patients and well-matched controls are warranted to confirm this finding.Keywords
This publication has 16 references indexed in Scilit:
- IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controlsBreast Cancer Research and Treatment, 2010
- Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjectsBreast Cancer Research and Treatment, 2009
- STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25,014 subjectsBreast Cancer Research and Treatment, 2009
- Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal womenBreast Cancer Research and Treatment, 2009
- Variant genotypes ofCDKN1AandCDKN1Bare associated with an increased risk of breast cancer in Chinese womenInternational Journal of Cancer, 2006
- Genetically determined subdivision of human populations with respect to the risk of breast cancer in womenDoklady Biological Sciences, 2006
- Lost in Transcription: p21 Repression, Mechanisms, and ConsequencesCancer Research, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Association studies for finding cancer-susceptibility genetic variantsNature Reviews Cancer, 2004
- Two variants of the CIP1/WAF1 gene occur together and are associated with human cancerHuman Molecular Genetics, 1995